Trial Profile
A Phase II Study of Flavopiridol (NSC# 649890) in Patients With Fludarabine Refractory B-Cell Chronic Lymphocytic Leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2013
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 11 Jan 2007 Status changed from in progress to completed
- 25 Sep 2005 New trial record.